BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37241027)

  • 1. Highly Selective Targeting of Pancreatic Cancer in the Liver with a Near-Infrared Anti-MUC5AC Probe in a PDOX Mouse Model: A Proof-of-Concept Study.
    Turner MA; Cox KE; Neel N; Amirfakhri S; Nishino H; Clary BM; Hosseini M; Natarajan G; Mallya K; Mohs AM; Hoffman RM; Batra SK; Bouvet M
    J Pers Med; 2023 May; 13(5):. PubMed ID: 37241027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescent Anti-MUC5AC Brightly Targets Pancreatic Cancer in a Patient-derived Orthotopic Xenograft.
    Turner MA; Hollandsworth HM; Nishino H; Amirfakhri S; Lwin TM; Lowy AM; Kaur S; Natarajan G; Mallya K; Hoffman RM; Batra SK; Bouvet M
    In Vivo; 2022; 36(1):57-62. PubMed ID: 34972700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-mucin 4 fluorescent antibody brightly targets colon cancer in patient-derived orthotopic xenograft mouse models: A proof-of-concept study for future clinical applications.
    Turner MA; Hollandsworth HM; Amirfakhri S; Lwin TM; Nishino H; Neel NC; Natarajan G; Kaur S; Mallya K; Hoffman RM; Batra SK; Bouvet M
    Am J Surg; 2022 Oct; 224(4):1081-1085. PubMed ID: 35715267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluorescent humanized anti-CEA antibody specifically labels metastatic pancreatic cancer in a patient-derived orthotopic xenograft (PDOX) mouse model.
    Lwin TM; Miyake K; Murakami T; DeLong JC; Amirfakhri S; Filemoni F; Yoon SN; Yazaki PJ; Shivley JE; Datnow B; Clary BM; Hoffman RM; Bouvet M
    Oncotarget; 2018 Dec; 9(99):37333-37342. PubMed ID: 30647873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylated Fluorescent Anti-carcinoembryonic Antigen Antibody Labels Colorectal Cancer Tumors in Orthotopic Mouse Models.
    Turner MA; Amirfakhri S; Nishino H; Neel NC; Hosseini M; Cox KE; Lwin TM; Li L; Hong T; Sherman A; Shively JE; Hoffman RM; Yazaki PJ; Bouvet M
    J Surg Res; 2023 Nov; 291():596-602. PubMed ID: 37540977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore.
    Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Katz MH; Fleming JB; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
    PLoS One; 2014; 9(12):e114310. PubMed ID: 25463150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Patient-Derived Orthotopic Xenograft Model of Gastroesophageal-Junction Adenocarcinoma Translated to the Clinic by Tumor-Targeting Fluorescent Antibodies to Carcinoembryonic-Antigen-Related Cell-Adhesion Molecules.
    Turner MA; Amirfakhri S; Nishino H; Lwin TM; Savides TJ; Reid TR; Singer BB; Hoffman RM; Bouvet M
    In Vivo; 2021; 35(4):1959-1963. PubMed ID: 34182469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.
    Lwin TM; Murakami T; Miyake K; Yazaki PJ; Shivley JE; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2018 Apr; 25(4):1079-1085. PubMed ID: 29372363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma.
    Dwertmann Rico S; Büscheck F; Dum D; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Perez D; Izbicki JR; Neipp M; Mofid H; Daniels T; Isbert C; Fraune C; Möller K; Menz A; Bernreuther C; Lebok P; Clauditz T; Sauter G; Uhlig R; Wilczak W; Simon R; Steurer S; Burandt E; Marx A; Krech T
    Int J Immunopathol Pharmacol; 2022; 36():3946320221106504. PubMed ID: 35764407
    [No Abstract]   [Full Text] [Related]  

  • 10. High Incidence of Lymph-node Metastasis in a Pancreatic-cancer Patient-derived Orthotopic Xenograft (PDOX) NOG-Mouse Model.
    Sugisawa N; Miyake K; Higuchi T; Oshiro H; Park JH; Kawaguchi K; Bouvet M; Unno M; Hoffman RM
    Anticancer Res; 2022 Feb; 42(2):739-743. PubMed ID: 35093872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humanized Fluorescent Tumor-associated Glycoprotein-72 Antibody Selectively Labels Colon-cancer Liver Metastases in Orthotopic Mouse Models.
    Hollandsworth HM; Nishino H; Turner M; Amirfakhri S; Filemoni F; Hoffman RM; Yazaki PJ; Bouvet M
    In Vivo; 2020; 34(5):2303-2307. PubMed ID: 32871754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-infrared fluorescence-guided resection of micrometastases derived from esophageal squamous cell carcinoma using a c-Met-targeted probe in a preclinical xenograft model.
    Liang M; Yang M; Wang F; Wang X; He B; Mei C; He J; Lin Y; Cao Q; Li D; Shan H
    J Control Release; 2021 Apr; 332():171-183. PubMed ID: 33636245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective efficacy of zoledronic acid on metastasis in a patient-derived orthotopic xenograph (PDOX) nude-mouse model of human pancreatic cancer.
    Hiroshima Y; Maawy AA; Katz MH; Fleming JB; Bouvet M; Endo I; Hoffman RM
    J Surg Oncol; 2015 Mar; 111(3):311-5. PubMed ID: 25394368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescent Anti-CEA Nanobody for Rapid Tumor-Targeting and Imaging in Mouse Models of Pancreatic Cancer.
    Lwin TM; Turner MA; Nishino H; Amirfakhri S; Hernot S; Hoffman RM; Bouvet M
    Biomolecules; 2022 May; 12(5):. PubMed ID: 35625638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory Mucin 5AC Promotes Neoplastic Progression by Augmenting KLF4-Mediated Pancreatic Cancer Cell Stemness.
    Ganguly K; Krishn SR; Rachagani S; Jahan R; Shah A; Nallasamy P; Rauth S; Atri P; Cox JL; Pothuraju R; Smith LM; Ayala S; Evans C; Ponnusamy MP; Kumar S; Kaur S; Batra SK
    Cancer Res; 2021 Jan; 81(1):91-102. PubMed ID: 33127746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humanized Anti-Tumor-Associated Glycoprotein-72 for Submillimeter Near-Infrared Detection of Colon Cancer in Metastatic Mouse Models.
    Hollandsworth HM; Amirfakhri S; Filemoni F; Hoffman RM; Molnar J; Yazaki PJ; Bouvet M
    J Surg Res; 2020 Aug; 252():16-21. PubMed ID: 32217350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) model resistant to neoadjuvant chemotherapy (NAC).
    Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
    Pancreatology; 2015; 15(3):295-301. PubMed ID: 25800176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Met-targeted near-infrared fluorescent probe for real-time depiction and dissection of perineural invasion and lymph node metastasis lesions in pancreatic ductal adenocarcinoma xenograft models.
    Li D; Yang M; Liang M; Mei C; Lin Y; Yang F; Xiao Y; Chen Y; Wang F; Mao J; Su Z
    Biomater Sci; 2021 Oct; 9(20):6737-6752. PubMed ID: 34254599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photoimmunotherapy Inhibits Tumor Recurrence After Surgical Resection on a Pancreatic Cancer Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.
    Hiroshima Y; Maawy A; Zhang Y; Guzman MG; Heim R; Makings L; Luiken GA; Kobayashi H; Tanaka K; Endo I; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1469-74. PubMed ID: 25893411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific Targeting and Labeling of Colonic Polyps in
    Turner MA; Cox KE; Liu S; Neel N; Amirfakhri S; Nishino H; Hosseini M; Alcantara JA; Abd El-Hafeez AA; Lwin TM; Mallya K; Pisegna JR; Singh SK; Ghosh P; Hoffman RM; Batra SK; Bouvet M
    Curr Issues Mol Biol; 2023 Apr; 45(4):3347-3358. PubMed ID: 37185743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.